Skip to content


    Exciting News for WebMD Members!

    We've been busy behind the scenes building new message boards for you. You'll have new and easier ways to find messages, connect with others, and share your stories.

    And, this will all be available on your smartphone or other mobile device!

    What Do You Need to Do?

    The message board you're used to will be closing in the coming weeks. While many of your boards will be making the move to our new home, your posts will not. Want to keep a discussion going? Save posts you want to continue (this includes your member profile story), so that you can re-post them in the new message boards.

    Keep an eye here and on your email inbox, we'll be back in touch soon to give you all the information you need!

    Yours in health,
    WebMD Message Boards Management

    Farewell to Statins?
    bobby75703 posted:
    Well, the big wigs are now fessing up on statin adverse events. What has been denied time and time again is now coming to surface in this article about a recent medscape video.

    "A slide is shown from the PRIMO observational study showing that 15% of people taking atorvastatin have significant adverse effects, and 20% of those taking simvastatin suffer significant adverse effects."

    "The discussion then opens out into the worrying problems with statins causing both diabetes and cognitive dysfunction (something vehemently denied for many, many years). Ballantyne was particularly eloquent on these issues."

    The article discussing the medscape video:
    iride6606 responded:
    This is a perfect example of cherry picking comments to make a point which is why very few people take Kendrick serious.

    Ballantyne's comments this past July;

    Nevertheless, the study confirms the tolerability of statins as a class, he said.

    "There is this risk of some diabetes and you have to check some liver function tests, which we've known about, but I think it's reassuring to physicians and patients that this is a safe class of drugs,"

    Here, you can hear for yourself from the doctor himself;

    Kendrick is all about selling books and promoting hype in my opinion.
    bobby75703 replied to iride6606's response:
    In my opinion Kendrick is a real man with real integrity. He doesn't sell out to Big Pharma. This guy is not a wimp.

    Kendrick's book sales are nothing compared to big pharma's statin sales.
    iride6606 replied to bobby75703's response:
    Kendrick's book sales are nothing compared to big pharma's statin sales.

    Not correct, three words; Economy of Scale,

    It's a statistical term that shows the economic effect of scale illustrated below;

    Simply put, your good doctor did not have $300M in development costs and another $100M in market costs to make the first return on his book. It's basics statistics 101 and I would be happy to step you through it, let me know.

    In my opinion Kendrick is a real man with real integrity. He doesn't sell out to Big Pharma. This guy is not a wimp.

    No, but he will take another doctor's quotes and cherry pick the bits and pieces that support his position. If you took the time to watch the video you will hear the exact quotes used in their entirety and in context. You will also hear for yourself the bits that were "picked" for his article, that's contrary to the threads you've posted before. So which is it?

    Featuring Experts

    There are no Expert stories for this community right now

    Helpful Tips

    Statin use is generally safe, and NOT associated with cancer and myopathy
    This network meta-analysis study provides evidence on the comparative tolerability and harms of individual statins. Overall, statins as a ... More
    Was this Helpful?
    1 of 2 found this helpful

    Helpful Resources

    Be the first to post a Resource!

    Related Drug Reviews

    • Drug Name User Reviews

    Report Problems With Your Medications to the FDA

    FDAYou are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.